Looking on the underlying holdi
Looking on the underlying holdings of the ETFs in our protection universe at ETF Channel, we now have in contrast the buying and selling worth of every holding towards the typical analyst 12-month ahead goal worth, and computed the weighted common implied analyst goal worth for the ETF itself. For the Vanguard S&P Mid-Cap 400 Development ETF (Image: IVOG), we discovered that the implied analyst goal worth for the ETF primarily based upon its underlying holdings is $219.88 per unit.
With IVOG buying and selling at a latest worth close to $197.54 per unit, that signifies that analysts see 11.31% upside for this ETF trying via to the typical analyst targets of the underlying holdings. Three of IVOG’s underlying holdings with notable upside to their analyst goal costs are Journey + Leisure Co (Image: TNL), Hain Celestial Group Inc (Image: HAIN), and Brinks Co (Image: BCO). Though TNL has traded at a latest worth of $65.03/share, the typical analyst goal is 15.84% greater at $75.33/share. Equally, HAIN has 15.77% upside from the latest share worth of $40.72 if the typical analyst goal worth of $47.14/share is reached, and analysts on common predict BCO to succeed in a goal worth of $88.00/share, which is 15.71% above the latest worth of $76.05. Beneath is a twelve month worth historical past chart evaluating the inventory efficiency of TNL, HAIN, and BCO:
Beneath is a abstract desk of the present analyst goal costs mentioned above:
.hctblstyle { font-family: Arial; font-size: 12px; width: 100%; }.hctblstyle th { padding: 2px; border-bottom: 1px stable #999999; background-color: #EFEFEF; }.hctblstyle td { padding: 2px; border-bottom: 1px stable #AAAAAA; background-color: #FEFEFE; }
| Identify | Image | Current Value | Avg. Analyst 12-Mo. Goal | % Upside to Goal |
|---|---|---|---|---|
| Vanguard S&P Mid-Cap 400 Development ETF | IVOG | $197.54 | $219.88 | 11.31% |
| Journey + Leisure Co | TNL | $65.03 | $75.33 | 15.84% |
| Hain Celestial Group Inc | HAIN | $40.72 | $47.14 | 15.77% |
| Brinks Co | BCO | $76.05 | $88.00 | 15.71% |
Are analysts justified in these targets, or overly optimistic about the place these shares might be buying and selling 12 months from now? Do the analysts have a sound justification for his or her targets, or are they behind the curve on latest firm and trade developments? A excessive worth goal relative to a inventory’s buying and selling worth can replicate optimism in regards to the future, however will also be a precursor to focus on worth downgrades if the targets have been a relic of the previous. These are questions that require additional investor analysis.
10 ETFs With Most Upside To Analyst Targets »
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.